Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial

INTRODUCTION: Recurrent pregnancy loss (RPL), defined as two or more consecutive pregnancy losses in the first trimester, affects around 5% of fertile women. The underlying causes remain unknown in up to 60% of patients; however, most studies point at an immunological pathology in unexplained RPL, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nørgaard-Pedersen, Caroline, Nielsen, Kaspar, Steffensen, Rudi, Eriksen, Line, Jørgensen, Malene Møller, Kesmodel, Ulrik Schiøler, Christiansen, Ole Bjarne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511589/
https://www.ncbi.nlm.nih.gov/pubmed/36137638
http://dx.doi.org/10.1136/bmjopen-2022-064780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511589/
https://www.ncbi.nlm.nih.gov/pubmed/36137638
http://dx.doi.org/10.1136/bmjopen-2022-064780

Ejemplares similares